The potential role of biologics in COPD The importance of mucus in bronchitic type Potential addition of Ensifentrine to COPD therapeutic options After over ten years with no drug of a new class approved for COPD, there’s at least some hope for progress.

Three standouts to me (as an ILD and acute lung injury doc/researcher...I'm biased to these sorts of talks):Tuesday, Clinical and Translational Studies in Mechanical Ventilation: RAPiD session, included studies investigating patient-vent interactions, treatment for septic shock, bioinformatics, and ...